Last Updated: June 27, 2026

Suppliers and packagers for locametz


✉ Email this page to a colleague

« Back to Dashboard


locametz

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Novartis LOCAMETZ gallium ga-68 gozetotide POWDER;INTRAVENOUS 215841 NDA Novartis Pharmaceuticals Corporation 0078-1224-61 1 VIAL, MULTI-DOSE in 1 CARTON (0078-1224-61) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSE 2022-03-23
Novartis LOCAMETZ gallium ga-68 gozetotide POWDER;INTRAVENOUS 215841 NDA Advanced Accelerator Applications USA, Inc 69488-017-61 1 VIAL, MULTI-DOSE in 1 CARTON (69488-017-61) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSE 2022-03-23
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Subscribe to access the full database, or Start Trial

Suppliers and packagers for locametz

Last updated: May 29, 2026

LocametZ (locametz) suppliers: who manufactures, distributes, and supplies the drug and API?

No sufficient information is available in the prompt to identify the drug’s correct generic name, dosage form, strength, NDA/BLA, or the specific product labeled “LOCAMETZ.” Without those identifiers, supplier and manufacturing sources cannot be mapped to FDA registrations, Orange Book listings, or verified commercial supply chain records.

What suppliers make LOCAMETZ and where are they registered in the FDA system?

No answer can be produced from the provided input.

What companies supply the active ingredient (API) for LOCAMETZ?

No answer can be produced from the provided input.

Which contract manufacturing organizations (CMOs) produce LOCAMETZ dosage forms?

No answer can be produced from the provided input.

How does the LOCAMETZ supply chain split between labeler, manufacturer, and distributor?

No answer can be produced from the provided input.

What is the Orange Book status of LOCAMETZ and does it change supplier availability?

No answer can be produced from the provided input.

Do any generic or biosimilar entrants for LOCAMETZ affect supplier options?

No answer can be produced from the provided input.

Which distributors carry LOCAMETZ in the US and what channels dominate procurement?

No answer can be produced from the provided input.

What packaging and label-supplier constraints apply to LOCAMETZ?

No answer can be produced from the provided input.

Key takeaways

No answer can be produced from the provided input.

FAQs

  1. What is the correct FDA identifier for “LOCAMETZ”?
  2. Who is the NDA/BLA holder for LOCAMETZ?
  3. Which firms are listed as drug substance manufacturers for LOCAMETZ?
  4. Which firms are listed as drug product manufacturers for LOCAMETZ?
  5. Which distributors are listed as responsible for LOCAMETZ supply in the US?

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links